Popular Keywords
Acute Leukemia
Chemotherapy
Hematology
Hematopoiesis
Interferon therapy
Leukemia virus
Editorial-Board
- Fengyan Jin, M.D./Ph.D.
The First Hospital of Jilin University, China - Salam Salim Alkindi
Sultan Qaboos University, Oman - Arthur S. Berg, PhD
University of California, USA - Ramasamy Harikrishnan,PhD
Bharathidasan University, India - Vittorio Montefusco
University of Bologna, Italy - Vittorio Montefusco
University of Bologna, Italy - Yao Dai
University of Florida, Gainesville - H¸«äseyin Engin
Bulent Ecevit University The School of Medicine, Turkey - Monika Lejman onet , PhD
Lublin, Medical School, Poland - Huseyin Engin
Bulent Ecevit University The School of Medicine, Turkey - Monika Lejman onet , PhD
Lublin, Medical School, Poland - Minodora-Cezarina OnisĆ¢i,MD, PhD
Emergency University Hospital Elias, Romania - Ludomira H. Granicka,PhD
Nalecz Institute of Biocybernetics and Biomedical Engineering, Poland - GAAFAR MOHAMED ABDEL-RASOUL
MENOUFIA UNIVERSITY, Egypt - Mohammad ali Mashhadi
Zahedan Univercity Of Medical Science, Iran - S. Hamid Sayar
Indiana University, Indianapolis, United States - Marwan A.Masri,PhD
Transmedical For Life S.A.R.L Sin El Fil, Lebanon - Anna Aureli
CNR, Institute of Translational Pharmacology (ITF), Italy - Kenneth Draper, PhD
International Scientific Associates, LLC, Reno, United States - Monika Lejman onet
University Children`s Hospital, Poland - Ladan Langroudi, PhD
Kerman University of medical sciences, Iran
Journal Info
- Journal Name: Journal of Leukemia Research
- Impact Factor: 1.6
- ISSN: 2831-3186
- DOI: 10.52338/ Jolr
- Short Name: JOLR
- Acceptance rate: 55%
- Volume: 6 (2024)
- Submission to acceptance: 25 days
- Acceptance to publication: 10 days
OUR PUBLICATION BENEFITS
- International Reach
- Peer Review
- Rapid Publication
- Open Access
- High Visibility